Novel cannabidiol−carbamate hybrids as selective BuChE inhibitors: Docking-based fragment reassembly for the development of potential therapeutic agents against Alzheimer's disease-Reference-Cited by-同舟云学术

Novel cannabidiol−carbamate hybrids as selective BuChE inhibitors: Docking-based fragment reassembly for the development of potential therapeutic agents against Alzheimer's disease

Published:2021-11 Issue: Volume:223 Page:113735
ISSN:0223-5234
Container-title:European Journal of Medicinal Chemistry
language:en
Short-container-title:European Journal of Medicinal Chemistry

Author:

Jiang Xia,Zhang Ziwen,Zuo Jiawei,Wu Chengyao,Zha Liang,Xu Yingying,Wang Sheng,Shi Jingbo,Liu Xin-Hua,Zhang Jing,Tang Wenjian^ORCID

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Pharmacology,General Medicine

Reference69 articles.

1. The World Alzheimer Report 2016;Price,2016

2. Mortality, morbidity, and risk factors in China and its provinces, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017;Zhou;Lancet,2019

3. A molecular network of the aging human brain provides insights into the pathology and cognitive decline of Alzheimer's disease;Mostafavi;Nat. Neurosci.,2018

4. Recent knowledge on medicinal plants as source of cholinesterase inhibitors for the treatment of dementia;Tundis;Mini Rev. Med. Chem.,2016

5. Kinetics of human serum butyrylcholinesterase inhibition by a novel experimental Alzheimer therapeutic, dihydrobenzodioxepine cymserine;Kamal;Neurochem. Res.,2008

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. 1,2,3-Triazole appended Schiff base functionalized silanes: A colorimetric sensor of Al (III) and a potent inhibitor of butyrylcholinesterase in Alzheimer’s diseases via molecular docking;Inorganica Chimica Acta;2024-11

2. Design, Synthesis, and Characterization of Novel Cannabidiol-Based Derivatives with Potent Antioxidant Activities;International Journal of Molecular Sciences;2024-09-04

3. Discovery of cinnamamide/ester triazole hybrids as potential treatment for Alzheimer’s disease;Bioorganic Chemistry;2024-09

4. Unveiling piperazine-quinoline hybrids as potential multi-target directed anti-Alzheimer’s agents: design, synthesis and biological evaluation;Molecular Diversity;2024-07-11

5. The Influence of an Acute Administration of Cannabidiol or Rivastigmine, Alone and in Combination, on Scopolamine-Provoked Memory Impairment in the Passive Avoidance Test in Mice;Pharmaceuticals;2024-06-20